Astheglobalpopulationagesandosteoarthritisprevalencerises—affectingover300millionpeopleworldwide—thedemandforareliableChondroitinSulfateSodiumManufacturerhasbecomeincreasinglycritical.Chondroitinsul
Astheglobalanticoagulantmarketcontinuestoexpand—projectedtoreachUSD65.45billionby2025—thedemandforareliableHeparinsManufacturerhasbecomeincreasinglycriticalforpharmaceuticalcompanies,healthcareprovi
Astheglobalburdenofthromboembolicdisorderscontinuestorise—withtheDalteparinSodiummarketprojectedtoreachUSD1990millionin2026andgrowata6.1%CAGRthrough2032—thedemandforhigh-quality,predictablelowmolecu
Inmoderncardiovascularandsurgicalhealthcare,EnoxaparinSodiumremainsthegold-standardlowmolecularweightheparin(LMWH),deliveringpredictable,safeanticoagulationformillionsworldwide.Astheglobalmarketsurges